Olmesartan Medoxomil CAS 144689-63-4 Puritas >99.5% (HPLC) API Factory

Description:

Nomen chemicum: Olmesartan Medoxomil

CAS: 144689-63-4

Puritas: >99.5% (HPLC)

Aspectus: Alba ad fere Albam Cyrstallinum Pulvis

Angiotensin II Receptor Antagon.Anti-Hypertensive

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum Olmesartan Medoxomil
Synonyma 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H- imidazole-5-carboxylicum Acidum (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester;CS-866
CAS Number 144689-63-4
CATTUS Number RF-PI1730
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C29H30N6O6
M. Pondus 558.60
Liquescens punctum 180 (dec.)
Aqua Solubility Insolubilis in aqua;Leviter solutum in DMSO
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus White ad fere album Cyrstalline pulveris
Lepidium sativum IR, HPLC, UV: Oportet Reference Latin
Puritas / Analysis Methodus >99.5% (HPLC in Anhydrous et Solvent-Free Basis)
Damnum in Siccatio <0.50%
Residere in Ignition <0.10%
Substantiae cognatae
Olmesartan RRT 0.2 <0.50%
Olmesartan Medoxoil Related Compone A. RRT 0.7 <0.20%
Olefinic Impuritas RRT 1.6 <0.50%
N-Alkyl Impuritas RRT 3.4 <0.10%
Alia immunditia <0.10%
Totalis immunditias <0.50%
Metalla gravia (ut Pb) <10ppm
pH Solutio (%, W/V) 4.5 ad 6.5
Test Standard Enterprise Latin;USP Standard
Consuetudinem API

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

Olmesartan Medoxomil (CS-866) (CAS: 144689-63-4) potens et selectivum angiotensin II typus 1 (AT(1)) receptor adversarius cum IC50 ex 66.2 μM, adhibitus in curatione pressurae sanguinis altae.Usus est ut anti-hypertensive.Olmesartan opera ligamen angiotensin II ad AT1 receptores in musculo vasculari obstruendo.Olmesartan obstringendo obligationem potius quam synthesim angiotensin II, vetat opiniones regulatorias negativas de secretione renini.Olmesartan Medoxomil est pro-medicamentum quod de-estificatum ad metabolitam activam, olmesartanam.Olmesartan Medoxomil in US Benicar deductum est, viva voce curatio hypertensionis administratum.

Epistulam tuam hic scribe et mitte nobis